SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+6.87%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$269M
AUM Growth
+$269M
(-8.1%)
Cap. Flow
-$28.2M
Cap. Flow
% of AUM
-10.48%
Top 10 Holdings %
Top 10 Hldgs %
26.22%
Holding
94
New
17
Increased
21
Reduced
26
Closed
21
Top Buys
| 1 |
HCA Healthcare
HCA
|
$7.47M |
| 2 |
Universal Health Services
UHS
|
$6.8M |
| 3 |
Viatris
VTRS
|
$5.08M |
| 4 |
Bristol-Myers Squibb
BMY
|
$4.6M |
| 5 |
Johnson & Johnson
JNJ
|
$4.19M |
Top Sells
| 1 |
Thermo Fisher Scientific
TMO
|
$8.51M |
| 2 |
Agilent Technologies
A
|
$6.74M |
| 3 |
Gilead Sciences
GILD
|
$6.48M |
| 4 |
AET
Aetna Inc
AET
|
$6.31M |
| 5 |
Revvity
RVTY
|
$6.21M |
Sector Composition
| 1 | Healthcare | 92.84% |
| 2 | Financials | 1.34% |
| 3 | Energy | 1.14% |
| 4 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
UnitedHealth
UNH
$281B
| $7.72M | 2.86% |
35,000
-10,000
| -22% | -$2.2M |
|
2
Molina Healthcare
MOH
$9.8B
| $7.67M | 2.85% |
100,000
+5,000
| +5% | +$383K |
|
|
3
HCA Healthcare
HCA
$94.5B
| $7.47M | 2.77% |
+85,000
| New | +$7.47M |
|
4
Centene
CNC
$14.3B
| $7.06M | 2.62% |
70,000
-10,000
| -13% | -$1.01M |
|
|
WCG
5
DELISTED
Wellcare Health Plans, Inc.
WCG
| $7.04M | 2.61% |
35,000
-10,000
| -22% | -$2.01M |
|
|
6
Universal Health Services
UHS
$11.6B
| $6.8M | 2.52% |
+60,000
| New | +$6.8M |
|
7
Elevance Health
ELV
$71.8B
| $6.75M | 2.51% |
30,000
-7,500
| -20% | -$1.69M |
|
8
Vertex Pharmaceuticals
VRTX
$100B
| $6.74M | 2.5% |
45,000
-5,000
| -10% | -$749K |
|
9
BioMarin Pharmaceuticals
BMRN
$11.2B
| $6.69M | 2.48% |
75,000
| – | – |
|
10
Incyte
INCY
$16.5B
| $6.63M | 2.46% |
70,000
+25,000
| +56% | +$2.37M |
|
11
Baxter International
BAX
$12.7B
| $6.46M | 2.4% |
100,000
-20,000
| -17% | -$1.29M |
|
12
Biogen
BIIB
$19.4B
| $6.37M | 2.36% |
20,000
-2,500
| -11% | -$796K |
|
13
AbbVie
ABBV
$372B
| $6.29M | 2.33% |
65,000
-30,000
| -32% | -$2.9M |
|
14
Abbott
ABT
$231B
| $6.28M | 2.33% |
110,000
-30,000
| -21% | -$1.71M |
|
15
Humana
HUM
$36.5B
| $6.2M | 2.3% |
25,000
-10,000
| -29% | -$2.48M |
|
16
Cigna
CI
$80.3B
| $6.09M | 2.26% |
30,000
-5,000
| -14% | -$1.02M |
|
17
Cencora
COR
$56.5B
| $5.51M | 2.04% |
60,000
+20,000
| +50% | +$1.84M |
|
18
Zimmer Biomet
ZBH
$21B
| $5.43M | 2.02% |
45,000
+20,000
| +80% | +$2.41M |
|
|
CELG
19
DELISTED
Celgene Corp
CELG
| $5.22M | 1.94% |
50,000
-5,000
| -9% | -$522K |
|
20
Teva Pharmaceuticals
TEVA
$21.1B
| $5.21M | 1.93% |
275,000
+175,000
| +175% | +$3.32M |
|
21
Intuitive Surgical
ISRG
$170B
| $5.11M | 1.9% |
14,000
+10,750
| +331% | +$3.92M |
|
|
22
Viatris
VTRS
$12.3B
| $5.08M | 1.88% |
+120,000
| New | +$5.08M |
|
|
ALXN
23
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $4.78M | 1.78% |
40,000
-20,000
| -33% | -$2.39M |
|
24
Boston Scientific
BSX
$156B
| $4.71M | 1.75% |
190,000
-70,000
| -27% | -$1.74M |
|
25
McKesson
MCK
$85.4B
| $4.68M | 1.74% |
30,000
+5,000
| +20% | +$780K |
|